Ozempic Now Approved Page for HCPs

Brand: Ozempic (semaglutide), Injection
Parent Company: Novo Nordisk
Drug Type: Boxed Warning
Drug Category: Endocrinology
Campaign: now-approved
Targeting: HCPs
Patient Website:
HCP Website: https://www.ozempicpro.com/